These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37722991)

  • 41. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
    Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
    Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement.
    Mayr NA; Montebello JF; Sorosky JI; Daugherty JS; Nguyen DL; Mardirossian G; Wang JZ; Edwards SM; Li W; Yuh WT
    Brachytherapy; 2005; 4(1):24-9. PubMed ID: 15737903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-dimensional transrectal ultrasound guided high-dose-rate prostate brachytherapy: A comparison of needle segmentation accuracy with two-dimensional image guidance.
    Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Montreuil J; D'Souza D; Fenster A; Wong E
    Brachytherapy; 2016; 15(2):231-9. PubMed ID: 26832673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies.
    Gutiérrez Miguélez C; Rodríguez Villalba S; Villafranca Iturre E; Fuentemilla Urio N; Richart Sancho J; Córdoba Lago S; Pino Sorroche F; Gracia Lucio R; Herreros Martínez A; Najjari-Jamal D;
    Clin Transl Oncol; 2023 Apr; 25(4):912-932. PubMed ID: 36445642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma.
    Weitmann HD; Knocke TH; Waldhäusl C; Pötter R
    Strahlenther Onkol; 2006 Feb; 182(2):86-95. PubMed ID: 16447015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy.
    Dise J; Liang X; Scheuermann J; Anamalayil S; Mesina C; Lin LL; Teo BK
    Brachytherapy; 2015; 14(5):619-25. PubMed ID: 26073225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
    D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
    Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program.
    Zelefsky MJ; Cohen GN; Taggar AS; Kollmeier M; McBride S; Mageras G; Zaider M
    Pract Radiat Oncol; 2017; 7(5):319-324. PubMed ID: 28377139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
    Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
    Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of dose to vaginal mucosa for gynecologic template interstitial high-dose-rate brachytherapy using Monte Carlo simulation.
    Elburg DV; Meyer T; Martell K; Quirk S; Roumeliotis M
    J Contemp Brachytherapy; 2023 Oct; 15(5):317-324. PubMed ID: 38026077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel multi-modality imaging phantom for validating interstitial needle guidance for high dose rate gynecological brachytherapy.
    Eckroate B; Ayala-Peacock D; Venkataraman R; Campelo S; Chino J; Stephens SJ; Kim Y; Meltsner S; Raffi J; Craciunescu O
    J Appl Clin Med Phys; 2023 Oct; 24(10):e14075. PubMed ID: 37335537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
    Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D era.
    Mendez LC; Lang P; Patel C; D'Souza D; Gladwish A; D'Alimonte L; Taggar A; Barnes E; Barbera L; Leung E
    Brachytherapy; 2019; 18(1):44-49. PubMed ID: 30316724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies.
    Nandwani PK; Vyas RK; Neema JP; Suryanarayan UK; Bhavsar DC; Jani KR
    J Cancer Res Ther; 2007; 3(2):111-5. PubMed ID: 17998736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
    Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
    Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.
    Wang W; Viswanathan AN; Damato AL; Chen Y; Tse Z; Pan L; Tokuda J; Seethamraju RT; Dumoulin CL; Schmidt EJ; Cormack RA
    Med Phys; 2015 Dec; 42(12):7114-21. PubMed ID: 26632065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.